Tuyen N. Bui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tuyen N. Bui has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Kelly K. Hunt
Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
43 shared publications - Khandan Keyomarsi
Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
43 shared publications - Yan Wang
Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
39 shared publications - Aysegul A. Sahin
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
27 shared publications - Mi Li
Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
27 shared publications - Cansu Karakas
Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
26 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Methods from Low–Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer
This file contains all the information pertaining to supplementary methods that were referred to in the supplementary data.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Methods from Low–Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer
This file contains all the information pertaining to supplementary methods that were referred to in the supplementary data.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figures and Legends from Low–Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer
This file includes all the 8 supplementary figures and their corresponding figure legends referred to in the main text.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures and Legends from Low–Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer
This file includes all the 8 supplementary figures and their corresponding figure legends referred to in the main text.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Low–Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer
Clinical and pathological characteristics of the 53 TNBC
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Low–Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer
Clinical and pathological characteristics of the 53 TNBC
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Low–Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer
Immune cell subset annotations and antibodies used for analysis.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Low–Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer
Immune cell subset annotations and antibodies used for analysis.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Tables from Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time
This file contains 6 supplementary tables referred to in the text of the manuscript
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables from Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time
This file contains 6 supplementary tables referred to in the text of the manuscript
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figures and Figure Legends from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers
The attached file contains 12 Supplemental Figures and Figure Legnds
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figures and Figure Legends from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers
The attached file contains 12 Supplemental Figures and Figure Legnds
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Materials and Methods from Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time
This file contains the description of supplementary materials and methods that is referred to in the manuscript
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Materials and Methods from Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time
This file contains the description of supplementary materials and methods that is referred to in the manuscript
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figures and Figure legends from Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time
This File contains all the supplemental figures and figure legends referred to in the main text.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figures and Figure legends from Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time
This File contains all the supplemental figures and figure legends referred to in the main text.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Materials and Methods from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers
This file contains all the supplementary materials and methods referred to in the text.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Materials and Methods from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers
This file contains all the supplementary materials and methods referred to in the text.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers
This file contains Supplementary Table 1, pertaining to the proteomic classification of RPPA antibodies
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers
This file contains Supplementary Table 1, pertaining to the proteomic classification of RPPA antibodies